Baguet Audrey, Reyngoudt Harmen, Pottier Andries, Everaert Inge, Callens Stefanie, Achten Eric, Derave Wim
Department of Movement and Sports Sciences, Ghent University, Ghent, Belgium.
J Appl Physiol (1985). 2009 Mar;106(3):837-42. doi: 10.1152/japplphysiol.91357.2008. Epub 2009 Jan 8.
Carnosine (beta-alanyl-L-histidine) is present in high concentrations in human skeletal muscles. The oral ingestion of beta-alanine, the rate-limiting precursor in carnosine synthesis, has been shown to elevate the muscle carnosine content both in trained and untrained humans. Little human data exist about the dynamics of the muscle carnosine content, its metabolic regulation, and its dependence on muscle fiber type. The present study aimed to investigate in three skeletal muscle types the supplementation-induced amplitude of carnosine synthesis and its subsequent elimination on cessation of supplementation (washout). Fifteen untrained males participated in a placebo-controlled double-blind study. They were supplemented for 5-6 wk with either 4.8 g/day beta-alanine or placebo. Muscle carnosine was quantified in soleus, tibialis anterior, and medial head of the gastrocnemius by proton magnetic resonance spectroscopy (MRS), before and after supplementation and 3 and 9 wk into washout. The beta-alanine supplementation significantly increased the carnosine content in soleus by 39%, in tibialis by 27%, and in gastrocnemius by 23% and declined post-supplementation at a rate of 2-4%/wk. Average muscle carnosine remained increased compared with baseline at 3 wk of washout (only one-third of the supplementation-induced increase had disappeared) and returned to baseline values within 9 wk at group level. Following subdivision into high responders (+55%) and low responders (+15%), washout period was 15 and 6 wk, respectively. In the placebo group, carnosine remained relatively constant with variation coefficients of 9-15% over a 3-mo period. It can be concluded that carnosine is a stable compound in human skeletal muscle, confirming the absence of carnosinase in myocytes. The present study shows that washout periods for crossover designs in supplementation studies for muscle metabolites may sometimes require months rather than weeks.
肌肽(β-丙氨酰-L-组氨酸)在人体骨骼肌中含量很高。口服肌肽合成的限速前体β-丙氨酸,已被证明能提高受过训练和未受过训练的人的肌肉肌肽含量。关于肌肉肌肽含量的动态变化、其代谢调节以及对肌纤维类型的依赖性,人类数据很少。本研究旨在调查三种骨骼肌类型中补充剂诱导的肌肽合成幅度及其在停止补充(洗脱)后的消除情况。15名未受过训练的男性参与了一项安慰剂对照双盲研究。他们被补充4.8克/天的β-丙氨酸或安慰剂,为期5 - 6周。在补充前后以及洗脱3周和9周时,通过质子磁共振波谱(MRS)对比目鱼肌、胫骨前肌和腓肠肌内侧头的肌肉肌肽进行定量。补充β-丙氨酸显著提高了比目鱼肌中肌肽含量39%,胫骨前肌中提高了27%,腓肠肌中提高了23%,补充后以2 - 4%/周的速度下降。在洗脱3周时,平均肌肉肌肽仍比基线水平升高(仅补充剂诱导增加量的三分之一消失),在9周时在组水平上恢复到基线值。在分为高反应者(增加55%)和低反应者(增加15%)后,洗脱期分别为15周和6周。在安慰剂组中,肌肽在3个月内相对保持恒定,变异系数为9 - 15%。可以得出结论,肌肽在人体骨骼肌中是一种稳定的化合物,证实了肌细胞中不存在肌肽酶。本研究表明,在肌肉代谢物补充研究的交叉设计中,洗脱期有时可能需要数月而非数周。